ActiveProtective® (APT) is proud to announce the launch of Tango® Belt, a wearable medical device utilizing sensors to monitor motion and deploy airbags during serious hip-impacting falls.

The Tango Belt, having already received Breakthrough Device Designation by the US Food and Drug Administration (FDA), was further granted marketing authorization as a prescription-only device intended as an adjunctive to standard-of-care to reduce the risk of hip fracture or hip dislocation due to falls in older adults at risk of major hip injury due to falls (DEN240021).

When used alongside standard-of-care in a multicenter premarket clinical study, the Tango Belt demonstrated paradigm-shifting outcomes, achieving a 91 percent reduction in fall-induced hip fractures in at-risk older adults as compared to the standard of care alone.

"Today marks a crucial step forward in addressing fall-induced hip fractures, a devastating injury that impacts countless lives of older adults every year," stated ActiveProtective's CEO, Wamis Singhatat. "With the FDA's marketing authorization and Breakthrough Device Designation of the Tango Belt, we are proud to introduce an innovation that sets a new standard for safer mobility and fall injury mitigation for at-risk older adults. This is the culmination of over a decade of unwavering dedication by our team of developers and clinicians. We are grateful to our partners and investors for making this vision a reality."

The Tango Belt can be comfortably worn day and night, and when used with its companion mobile app, automatically alerts family and care staff when a fall or impact is detected. The mobile app's easy-to-read dashboard displays key metrics including balance confidence and adherence.

APT is now seeking interested senior living owner/operators, healthcare systems and providers, particularly those in Value-Based Care models that proactively "screen and intervene" to mitigate risk and avoid costly episodes of care.